SNDL Inc (SNDL) Analyst Ratings & Price Targets
Wall Street analyst consensus, individual price targets, and rating history for SNDL.
$1.35+0.74%
HoldConsensus Rating
3.2
Hold
Based on 5 analysts
Strong SellSellHoldBuyStrong Buy
Strong Buy
1
Buy
1
Hold
2
Sell
0
Strong Sell
1
Price Target Summary
Average Target
$1.66
High Target
$2.24
Low Target
$1.09
Upside
+22.5%
Price Target vs Current Price
Current ($1.35)
Avg Target ($1.66)
Target Range
Individual Analyst Ratings
| Firm | Rating | Price Target |
|---|---|---|
| Piper Sandler | Hold | $2.15 |
| Stifel | Hold | $2.24 |
| Cowen | Strong Sell | $1.09 |
| Alliance Global Partners | Strong Buy | $1.18 |
| Cantor Fitzgerald | Buy | $1.66 |
Rating History
| Quarter | Consensus | Avg Target | # Analysts |
|---|---|---|---|
| Q1 2025 | Hold | $1.67 | 5 |
| Q2 2025 | Hold | $1.88 | 3 |
| Q3 2025 | Buy | $1.50 | 4 |
| Q4 2025 | Hold | $1.70 | 5 |
Frequently Asked Questions
What do analyst ratings mean for SNDL?+
Analyst ratings represent professional Wall Street analysts' recommendations on whether to buy, hold, or sell SNDL Inc (SNDL) stock. Ratings typically range from "Strong Buy" (most bullish) to "Strong Sell" (most bearish). Each rating comes with a price target, which is the analyst's estimate of where the stock price will be in 12 months. These ratings are based on fundamental analysis, industry research, and financial modeling.
How reliable are cannabis stock price targets for SNDL?+
Price targets for cannabis stocks like SNDL should be viewed as directional estimates rather than precise predictions. Cannabis analyst coverage is limited compared to other sectors, and the industry faces unique regulatory uncertainties that make forecasting difficult. Historically, analyst price targets across all sectors are accurate about 50% of the time. For cannabis stocks, accuracy may be lower due to rapid regulatory changes, evolving competitive dynamics, and the sector's relative immaturity.
What is a consensus rating?+
A consensus rating is the average recommendation across all analysts covering a stock. For SNDL, the consensus score of 3.2 out of 5.0 reflects the combined view of 5 analysts. A score above 3.5 generally indicates a "Buy" consensus, 2.5-3.5 is "Hold," and below 2.5 is "Sell." The consensus provides a more balanced view than any single analyst's opinion.
How many analysts cover SNDL?+
SNDL Inc (SNDL) is currently covered by 5 analysts. Cannabis stocks typically have fewer analysts compared to large-cap stocks in other sectors, which often have 15-30 analysts. Limited coverage is common in the cannabis industry because many major investment banks restrict cannabis coverage due to federal illegality concerns. Firms like Cantor Fitzgerald, BTIG, and Piper Sandler are among the most active cannabis stock analysts.
What is the difference between buy, hold, and sell ratings?+
A "Buy" or "Strong Buy" rating means the analyst believes the stock will outperform the market and recommends purchasing shares. A "Hold" rating suggests the stock is fairly valued and investors should maintain their current position. A "Sell" or "Strong Sell" rating indicates the analyst expects the stock to underperform and recommends reducing or eliminating the position. For SNDL, the current consensus is "Hold" based on 2 buy-side ratings, 2 holds, and 1 sell-side ratings.
How should I use analyst ratings in my SNDL investment decisions?+
Analyst ratings should be one input among many in your investment research, not the sole basis for decisions. Consider the analyst's track record, the recency of the rating, and whether the price target accounts for cannabis-specific risks like regulatory changes and Section 280E tax implications. Compare analyst views with your own research on SNDL Inc's financials, competitive position, and growth prospects. Remember that analysts may have conflicts of interest and their recommendations can lag behind rapidly changing market conditions.
Simulated Data Disclaimer
The analyst ratings, price targets, and consensus data shown on this page are simulated for educational and illustrative purposes only. They do not represent actual analyst opinions or real investment research. Do not make investment decisions based on this data. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.